In IBD patients, specific antisense oligonucleotides restore TGFβ signaling and inhibit cytokine production, meaning that SMAD7 blockade of TGFβ signaling maintains chronic production of proinflammatory cytokines [44]. This evidence concerns the gene TGFB1 and inflammatory bowel disease.